Comparison of clinical and sociodemographic features of bipolar disorder patients with those of social anxiety disorder patients comorbid with bipolar disorder in Turkey

References

1. ↵
   1. Goes FS

   (2015) The importance of anxiety states in bipolar disorder. Curr Psychiatry Rep 17:3.
2. ↵
   1. Goes FS,
   2. McCusker MG,
   3. Bienvenu OJ,
   4. Mackinnon DF,
   5. Mondimore FM,
   6. Schweizer B,
   7. et al.

   (2012) Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder. Psychol Med 42:1449–1459.
3. ↵
   1. Levy B,
   2. Tsoy E,
   3. Brodt M,
   4. Petrosyan K,
   5. Malloy M

   (2015) Stigma, social anxiety, and illness severity in bipolar disorder: Implications for treatment. Ann Clin Psychiatry 27:55–64.
4. ↵
   1. Lee JH,
   2. Dunner DL

   (2008) The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Depress Anxiety 25:91–97.
5. 1. O'Garro-Moore JK,
   2. Adams AM,
   3. Abramson LY,
   4. Alloy LB

   (2015) Anxiety comorbidity in bipolar spectrum disorders: the mediational role of perfectionism in prospective depressive symptoms. J Affect Disord 174:180–187.
6. ↵
   1. Koyuncu A,
   2. Ertekin E,
   3. Binbay Z,
   4. Ozyildirim I,
   5. Yuksel C,
   6. Tukel R

   (2014) The clinical impact of mood disorder comorbidity on social anxiety disorder. Compr Psychiatry 55:363–369.
7. ↵
   1. Hawke LD,
   2. Provencher MD,
   3. Parikh SV,
   4. Zagorski B

   (2013) Comorbid anxiety disorders in Canadians with bipolar disorder: clinical characteristics and service use. Can J Psychiatry 58:393–401.
8. ↵
   1. Koyuncu A,
   2. Ertekin E,
   3. Ertekin BA,
   4. Binbay Z,
   5. Yuksel C,
   6. Deveci E

   (2015) Relationship between atypical depression and social anxiety disorder. Psychiatry Res 225:79–84.
9. ↵
   1. Van Den Berg B,
   2. Penninx BW,
   3. Zitman FG,
   4. Nolen WA

   (2010) Manic symptoms in patients with depressive and/or anxiety disorders. J Affect Disord 126:252–256.
10. 1. Munoli RN,
    2. Praharaj SK,
    3. Sharma PS

    (2014) Co-morbidity in bipolar disorder: a retrospective study. Indian J Psychol Med 36:270–275.
11. ↵
    1. Kim SW,
    2. Berk L,
    3. Kulkarni J,
    4. Dodd S,
    5. de Castella A,
    6. Fitzgerald PB

    (2014) Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder. J Affect Disord 166:243–248.
12. ↵
    1. Provencher MD,
    2. Guimond AJ,
    3. Hawke LD

    (2012) Comorbid anxiety in bipolar spectrum disorders: a neglected research and treatment issue? J Affect Disord 137:161–164.
13. ↵
    1. Goes FS,
    2. McCusker MG,
    3. Bienvenu OJ,
    4. Mackinnon DF,
    5. Mondimore FM,
    6. Schweizer B

    (2012) Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder. Psychol Med 42:1449–1459.
14. ↵
    1. Albert U,
    2. Rosso G,
    3. Maina G,
    4. Bogetto F

    (2008) Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Affect Disord 105:297–303.
15. ↵
    1. Merikangas KR,
    2. Paksarian D

    (2015) Update on epidemiology, risk factors and correlates of bipolar spectrum disorder. The Bipolar Book. History, Neurobiology, and Treatment, 414–454.
16. ↵
    1. Nielsen J,
    2. Kane JM,
    3. Correll CU

    (2012) Real-worldeffectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study. Bipolar Disord 14:863–869.
17. ↵
    1. Holma KM,
    2. Melartin TK,
    3. Holma IA,
    4. Isometsä ET

    (2008) Predictors for switch from unipolar major depressive disorder to bipolar disorder type I or II: a 5-year prospective study. J Clin Psychiatry 69:1267–1275.
18. ↵
    1. Himmelhoch JM

    (1998) Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues. J Affect Disord 50:203–213.
19. ↵
    1. Johannessen Landmark C

    (2008) Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs 22:27–47.
20. ↵
    1. Koenders MA,
    2. Nolen WA,
    3. Giltay EJ,
    4. Hoencamp E,
    5. Spijker AT

    (2015) The use of the prospective NIMH Life Chart Method as a bipolar mood assessment method in research: a systematic review of different methods, outcome measures and interpretations. J Affect Disord 175:260–268.